| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 10/01/2002 | US6458948 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 10/01/2002 | US6458785 Aids therapy |
| 10/01/2002 | US6458769 Amorphous lisinopril having the formula (s)-1-(n.sup.2 -(1-carboxy-3-phenylpropyl))-l-lysyl)-l-proline, wherein amorphous lisinopril has a glass transition point (tg) when dry, measured by thermal mehanical analysis |
| 10/01/2002 | US6458767 Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease |
| 10/01/2002 | US6458760 Comprising administering to said patient a therapeutically effective amount of a compound which is a specific inhibitor of either cathepsin b or cathepsin l, but which is not as effective inhibitor of calpain |
| 10/01/2002 | US6458349 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 10/01/2002 | CA2210258C Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 10/01/2002 | CA2168113C Therapeutic peptide derivatives |
| 10/01/2002 | CA2124087C Combinatorial strategies for polymer synthesis |
| 10/01/2002 | CA2069256C Method of preparing .alpha.-l-aspartyl-l-phenylalanine methyl ester |
| 09/26/2002 | WO2002074792A1 Fo-6979 substances and process for producing the same |
| 09/26/2002 | WO2002074761A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/26/2002 | WO2002074293A2 Methods for restoring cognitive function following systemic stress |
| 09/26/2002 | WO2002074050A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 09/26/2002 | WO2002036173A3 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 09/26/2002 | WO2002030922A3 Dioxolane analogs for improved inter-cellular delivery |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137942 HIV protease inhibitors; administering to treat AIDS (acquired immune deficiency syndrome) |
| 09/26/2002 | US20020137730 Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/26/2002 | US20020137672 Radiolabeled annexins |
| 09/26/2002 | US20020137177 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme |
| 09/26/2002 | CA2442717A1 Methods for restoring cognitive function following systemic stress |
| 09/26/2002 | CA2441822A1 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 09/25/2002 | EP1243594A1 Process for crystallizing N2-((S)-1-ethoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysyl-L-proline |
| 09/25/2002 | EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | EP1242070A2 Treatment of ischemic brain injuries with brain targetted antioxidant compounds |
| 09/25/2002 | EP0871656B1 Dolastatin derivatives, their preparation and use |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1370778A Beta-tetrahydro carboline carboxylic acid, its RGD conjugate, their synthesis and medical application |
| 09/24/2002 | US6455705 Distillation-free; chemical intermediates for the production of angiotensin-converting enzyme (ace) inhibitors |
| 09/24/2002 | US6455671 Thrombin inhibitors, the preparation and use thereof |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455500 Radiation therapy methods |
| 09/24/2002 | US6455244 Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents |
| 09/24/2002 | CA2096223C Treatment for tissue ulceration |
| 09/19/2002 | WO2002073208A2 Anti-epileptogenic agents |
| 09/19/2002 | WO2002072629A1 Immunopotentiators |
| 09/19/2002 | WO2002072618A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | WO2002072617A1 Thiopeptide compounds |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072609A2 Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| 09/19/2002 | WO2002072151A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/19/2002 | WO2002018341A3 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 09/19/2002 | WO2001025264A9 Substituted phosphinate based peptide derivatives |
| 09/19/2002 | US20020133037 Artificial sweetener |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020132779 Analogs of L-Glu-L-Trp having pharmacological activity |
| 09/19/2002 | US20020132776 Inhibitors of transglutaminase |
| 09/19/2002 | US20020132765 Powerful activity when administered orally and by injection so that they can be used in a hospital environment via injection, followed by an oral ambulatory treatment |
| 09/19/2002 | US20020132300 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| 09/19/2002 | US20020132032 Alkylating aspartame with a benzene or benzodioxole aldehyde to produce a aspartyl dipeptide ester derivative; food or drink sweeteners |
| 09/19/2002 | CA2470152A1 Transfection complexes comprising a novel peptide as cell surface receptor binding component |
| 09/19/2002 | CA2441210A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | CA2440834A1 Anti-epileptogenic agents |
| 09/19/2002 | CA2440353A1 Thiopeptide compounds |
| 09/19/2002 | CA2439897A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/19/2002 | CA2439236A1 Immuno-enhancing agent |
| 09/18/2002 | EP1240193A2 Peptide fragments of colostrinin |
| 09/18/2002 | EP1240169A1 Peptide beta-turn mimetic compounds and processes for making them |
| 09/18/2002 | EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/18/2002 | EP1239877A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN $g(a) V?$g(b) 3? RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 09/18/2002 | CN1370181A Effectors of dipeptidyl peptidase IV for topical use |
| 09/18/2002 | CN1370078A Prion protein peptides and uses thereof |
| 09/17/2002 | US6451972 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 09/17/2002 | US6451971 Polypeptide cell adhesion inhibitors; antimetastasis and anticarcinogenic agents |
| 09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
| 09/17/2002 | US6451853 Small molecules that elicit a polarized Th1 response and for modulation of cellular immunity |
| 09/17/2002 | US6451761 N′N′-dichlorinated omega-amino acids and uses thereof |
| 09/17/2002 | US6451760 Treatment of inflammation using a 2F1 polypeptide or an antibody thereto |
| 09/17/2002 | CA2129976C Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme |
| 09/12/2002 | WO2002070545A2 Siderophore analogues as tetra- or hexadentate iron chelators on the basis of amino acids or peptides, method for producing them and the use thereof |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/12/2002 | WO2002070018A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | WO2002069905A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | WO2002069884A2 A sunburn treatment and sunburn prevention method |
| 09/12/2002 | WO2002050100A3 Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery |
| 09/12/2002 | WO2001016372A9 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 09/12/2002 | US20020128473 Derivatives of octahydro-6, 10-dioxo-6H-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, useful for preperation of therapeutically active compounds |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128206 Such as 6-Amino-2-(2-((1-benzenesulfonyl-piperidine-4-carbonyl)-amino)-3-(1H-indol-3-yl)-propionylamino)-hexanoic acid tert-butyl ester for promotes secretion of growth hormone; gene expression |
| 09/12/2002 | US20020127629 Imaging of enzymatic activity |
| 09/12/2002 | US20020127320 Subjecting a 2-hydroxychroman compound and aspartame to a reductive alkylation reaction to produce N-(N-(3-(2-hydroxy-substituted phenyl)propyl)-L- alpha -aspartyl)-L-phenylalanine 1-methyl ester compound |
| 09/12/2002 | CA2439691A1 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | CA2439579A1 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/11/2002 | EP1239037A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| 09/11/2002 | EP1238678A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/11/2002 | EP1237878A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 09/11/2002 | EP1054892B1 Azole peptidomimetics as thrombin receptor antagonists |
| 09/11/2002 | EP0853484B1 Novel mu opioid receptor ligands: agonists and antagonists |
| 09/11/2002 | EP0603399B1 Endothelin-antagonizing peptide |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1090637C Cross-link cinnamic acid derivative and its preparation method |
| 09/11/2002 | CN1090508C Storage stable water solution for infusion containing thrombin inhibitor |